Product Code: ETC206076 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The Indiaisosorbide mononitrate market is expected to register a CAGR of 8.9% over the forecast period (2025-2031). The rising prevalence of cardiovascular diseases, coupled with growing demand for long acting nitrates in the management of angina pectoris and heart failure are among some of the key factors driving growth in this market. Additionally, increasing geriatric population and rising awareness about better health care initiatives have been adding to the overall growth potential for the India isosorbide mononitrate market.
Government initiatives to provide affordable healthcare facilities and easy availability through online pharmacies is aiding the growth of this market further. However, generic drugs possessing similar effects can hamper the growth prospects for brands selling Isosorbide Mononitrate at premium prices. Also, stringent regulatory policies may hinder its sales in certain parts of India due to lack or absence of approval from relevant authorities like DCGI (Drugs Controller General Of India). Nevertheless, expansion into untapped rural areas will create new opportunities for players operating within this industry landscape over the forecast period 2025-2031.
Certain drawbacks such as high costs associated with product development stages along with limited availability may hinder the overall growth prospects for this industry during 2025-2031. Furthermore, stringent regulation by government authorities regarding quality standards have also been impacting market performance negatively. Moreover, COVID-19 pandemic has made a considerable impact on global business activities due to disruption in supply chain & logistics which will eventually lead to reduced revenue generation from sales activity across different sectors including healthcare drugs and medicines sector as well.
Major players operating in India isosorbide mononitrate industry include Sanofi Aventis Pharma Private Limited., Pfizer Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Abbott Healthcare Pvt Ltd., Torrent Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Wockhardt Ltd., Ranbaxy Laboratories Limited etc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Isosorbide Mononitrate Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Isosorbide Mononitrate Market Revenues & Volume, 2021 & 2031F |
3.3 India Isosorbide Mononitrate Market - Industry Life Cycle |
3.4 India Isosorbide Mononitrate Market - Porter's Five Forces |
3.5 India Isosorbide Mononitrate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Isosorbide Mononitrate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Isosorbide Mononitrate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in India |
4.2.2 Growing awareness about the benefits of isosorbide mononitrate in treating heart conditions |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for pharmaceutical products in India |
4.3.2 Presence of alternative treatment options for cardiovascular diseases |
4.3.3 Limited availability of skilled healthcare professionals specializing in cardiovascular care in certain regions of India |
5 India Isosorbide Mononitrate Market Trends |
6 India Isosorbide Mononitrate Market, By Types |
6.1 India Isosorbide Mononitrate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Isosorbide Mononitrate Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 India Isosorbide Mononitrate Market Revenues & Volume, By 10 mg Tablet, 2021-2031F |
6.1.4 India Isosorbide Mononitrate Market Revenues & Volume, By 20 mg Tablet, 2021-2031F |
6.2 India Isosorbide Mononitrate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Isosorbide Mononitrate Market Revenues & Volume, By Treatment of angina pectoris, 2021-2031F |
6.2.3 India Isosorbide Mononitrate Market Revenues & Volume, By Others, 2021-2031F |
7 India Isosorbide Mononitrate Market Import-Export Trade Statistics |
7.1 India Isosorbide Mononitrate Market Export to Major Countries |
7.2 India Isosorbide Mononitrate Market Imports from Major Countries |
8 India Isosorbide Mononitrate Market Key Performance Indicators |
8.1 Number of prescriptions for isosorbide mononitrate by healthcare providers |
8.2 Patient adherence and compliance rates to isosorbide mononitrate treatment |
8.3 Number of clinical trials and studies conducted on the efficacy of isosorbide mononitrate in India |
9 India Isosorbide Mononitrate Market - Opportunity Assessment |
9.1 India Isosorbide Mononitrate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Isosorbide Mononitrate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Isosorbide Mononitrate Market - Competitive Landscape |
10.1 India Isosorbide Mononitrate Market Revenue Share, By Companies, 2024 |
10.2 India Isosorbide Mononitrate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |